Users Discontinuing Anti-Obesity Jabs Put On Pounds Four Times Faster Than Dieters

New research suggests that individuals who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end traditional diet and exercise regimens.

Research printed in a major health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.

"People using these medications need to be cognizant of the risk of fast rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery means a return to starting weight in about one and a half years.

Comparing Treatments

The research, which examined 37 of studies involving thousands of participants, compared the results of the injectable medications with other pills.

Scientists point out that individuals who shed pounds through diet and exercise generally see a more gradual weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Fast Regain

Nutrition scientists suggest the way of the injections accounts for the accelerated rebound.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Sustained high doses of GLP-1 levels far above than the body's typical production could lead to the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication leads to appetite is no longer kept in check, making overeating far more likely."

A Chronic Disease?

The NHS suggest the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Professionals say that, considering the likelihood of relapse, the treatment is often life-long.

This opinion is echoed by drug manufacturers, who say that the results "highlight the chronic character of excess weight," similar to managing diseases like diabetes.

Patient Accounts

People who have stopped the jabs explain a sudden return of appetite.

"It was like something that goes on and you become ravenous," recalled a patient.

This challenge is compounded if users have not developed sustainable dietary or behavioural changes during treatment.

Widespread Interest

Figures indicate that millions of people in the UK have used these injections in the last 12 months, with demand continuing to grow.

• Adoption is more common among females compared to men.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, experts emphasize that while the jabs are potent agents for weight loss, they are not a standalone solution and maintained weight loss hinges on integrated behavioural management.